カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の敗血症治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Sepsis Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19620）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19620
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：100
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の敗血症治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

敗血症治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の敗血症治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

敗血症治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・セファロスポリン、ペンシル、マクロライド、その他

用途別セグメントは次のように区分されます。
・敗血症、重症敗血症、敗血症性ショック

世界の敗血症治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、NCPC、Bayer、Shanghai Pharmaceuticals、Johnson & Johnson、Novartis、GlaxoSmithKline、TEVA、Mylan、Allergan、Merck & Co

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、敗血症治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な敗血症治療薬メーカーの企業概要、2019年～2022年までの敗血症治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な敗血症治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別敗血症治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの敗血症治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での敗血症治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および敗血症治療薬の産業チェーンを掲載しています。
・第13、14、15章では、敗血症治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 敗血症治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：セファロスポリン、ペンシル、マクロライド、その他
- 用途別分析（2017年vs2021年vs2028年）：敗血症、重症敗血症、敗血症性ショック
- 世界の敗血症治療薬市場規模・予測
- 世界の敗血症治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、NCPC、Bayer、Shanghai Pharmaceuticals、Johnson & Johnson、Novartis、GlaxoSmithKline、TEVA、Mylan、Allergan、Merck & Co
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：セファロスポリン、ペンシル、マクロライド、その他
・用途別分析2017年-2028年：敗血症、重症敗血症、敗血症性ショック
・敗血症治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・敗血症治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・敗血症治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・敗血症治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・敗血症治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Sepsis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Sepsis Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Sepsis accounting for % of the Sepsis Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cephalosporin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Sepsis Drug include Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sepsis Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cephalosporin
Pencillin
Macrolides
Others
Market segment by Application can be divided into
Sepsis
Severe Sepsis
Septic Shock
The key market players for global Sepsis Drug market are listed below:
Pfizer
NCPC
Bayer
Shanghai Pharmaceuticals
Johnson & Johnson
Novartis
GlaxoSmithKline
TEVA
Mylan
Allergan
Merck & Co
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sepsis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sepsis Drug, with price, sales, revenue and global market share of Sepsis Drug from 2019 to 2022.
Chapter 3, the Sepsis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sepsis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sepsis Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sepsis Drug.
Chapter 13, 14, and 15, to describe Sepsis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Sepsis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sepsis Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Cephalosporin
1.2.3 Pencillin
1.2.4 Macrolides
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sepsis Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Sepsis
1.3.3 Severe Sepsis
1.3.4 Septic Shock
1.4 Global Sepsis Drug Market Size & Forecast
1.4.1 Global Sepsis Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sepsis Drug Sales in Volume (2017-2028)
1.4.3 Global Sepsis Drug Price (2017-2028)
1.5 Global Sepsis Drug Production Capacity Analysis
1.5.1 Global Sepsis Drug Total Production Capacity (2017-2028)
1.5.2 Global Sepsis Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sepsis Drug Market Drivers
1.6.2 Sepsis Drug Market Restraints
1.6.3 Sepsis Drug Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Sepsis Drug Product and Services
2.1.4 Pfizer Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 NCPC
2.2.1 NCPC Details
2.2.2 NCPC Major Business
2.2.3 NCPC Sepsis Drug Product and Services
2.2.4 NCPC Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Sepsis Drug Product and Services
2.3.4 Bayer Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shanghai Pharmaceuticals
2.4.1 Shanghai Pharmaceuticals Details
2.4.2 Shanghai Pharmaceuticals Major Business
2.4.3 Shanghai Pharmaceuticals Sepsis Drug Product and Services
2.4.4 Shanghai Pharmaceuticals Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Sepsis Drug Product and Services
2.5.4 Johnson & Johnson Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Sepsis Drug Product and Services
2.6.4 Novartis Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Sepsis Drug Product and Services
2.7.4 GlaxoSmithKline Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 TEVA
2.8.1 TEVA Details
2.8.2 TEVA Major Business
2.8.3 TEVA Sepsis Drug Product and Services
2.8.4 TEVA Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Sepsis Drug Product and Services
2.9.4 Mylan Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Allergan
2.10.1 Allergan Details
2.10.2 Allergan Major Business
2.10.3 Allergan Sepsis Drug Product and Services
2.10.4 Allergan Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Merck & Co
2.11.1 Merck & Co Details
2.11.2 Merck & Co Major Business
2.11.3 Merck & Co Sepsis Drug Product and Services
2.11.4 Merck & Co Sepsis Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Sepsis Drug Breakdown Data by Manufacturer
3.1 Global Sepsis Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sepsis Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sepsis Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Sepsis Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Sepsis Drug Manufacturer Market Share in 2021
3.5 Global Sepsis Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sepsis Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sepsis Drug Market Size by Region
4.1.1 Global Sepsis Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Sepsis Drug Revenue by Region (2017-2028)
4.2 North America Sepsis Drug Revenue (2017-2028)
4.3 Europe Sepsis Drug Revenue (2017-2028)
4.4 Asia-Pacific Sepsis Drug Revenue (2017-2028)
4.5 South America Sepsis Drug Revenue (2017-2028)
4.6 Middle East and Africa Sepsis Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Sepsis Drug Sales in Volume by Type (2017-2028)
5.2 Global Sepsis Drug Revenue by Type (2017-2028)
5.3 Global Sepsis Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Sepsis Drug Sales in Volume by Application (2017-2028)
6.2 Global Sepsis Drug Revenue by Application (2017-2028)
6.3 Global Sepsis Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Sepsis Drug Sales by Type (2017-2028)
7.2 North America Sepsis Drug Sales by Application (2017-2028)
7.3 North America Sepsis Drug Market Size by Country
7.3.1 North America Sepsis Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Sepsis Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Sepsis Drug Sales by Type (2017-2028)
8.2 Europe Sepsis Drug Sales by Application (2017-2028)
8.3 Europe Sepsis Drug Market Size by Country
8.3.1 Europe Sepsis Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Sepsis Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Sepsis Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Sepsis Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Sepsis Drug Market Size by Region
9.3.1 Asia-Pacific Sepsis Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sepsis Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Sepsis Drug Sales by Type (2017-2028)
10.2 South America Sepsis Drug Sales by Application (2017-2028)
10.3 South America Sepsis Drug Market Size by Country
10.3.1 South America Sepsis Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Sepsis Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sepsis Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Sepsis Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Sepsis Drug Market Size by Country
11.3.1 Middle East & Africa Sepsis Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sepsis Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Sepsis Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sepsis Drug
12.3 Sepsis Drug Production Process
12.4 Sepsis Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sepsis Drug Typical Distributors
13.3 Sepsis Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Sepsis Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Sepsis Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Sepsis Drug Product and Services
Table 6. Pfizer Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. NCPC Basic Information, Manufacturing Base and Competitors
Table 8. NCPC Major Business
Table 9. NCPC Sepsis Drug Product and Services
Table 10. NCPC Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Sepsis Drug Product and Services
Table 14. Bayer Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Shanghai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Shanghai Pharmaceuticals Major Business
Table 17. Shanghai Pharmaceuticals Sepsis Drug Product and Services
Table 18. Shanghai Pharmaceuticals Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Sepsis Drug Product and Services
Table 22. Johnson & Johnson Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Sepsis Drug Product and Services
Table 26. Novartis Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 28. GlaxoSmithKline Major Business
Table 29. GlaxoSmithKline Sepsis Drug Product and Services
Table 30. GlaxoSmithKline Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. TEVA Basic Information, Manufacturing Base and Competitors
Table 32. TEVA Major Business
Table 33. TEVA Sepsis Drug Product and Services
Table 34. TEVA Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Mylan Basic Information, Manufacturing Base and Competitors
Table 36. Mylan Major Business
Table 37. Mylan Sepsis Drug Product and Services
Table 38. Mylan Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Allergan Basic Information, Manufacturing Base and Competitors
Table 40. Allergan Major Business
Table 41. Allergan Sepsis Drug Product and Services
Table 42. Allergan Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 44. Merck & Co Major Business
Table 45. Merck & Co Sepsis Drug Product and Services
Table 46. Merck & Co Sepsis Drug Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Sepsis Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 48. Global Sepsis Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Sepsis Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Sepsis Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Sepsis Drug Production Site of Key Manufacturer
Table 52. Sepsis Drug New Entrant and Capacity Expansion Plans
Table 53. Sepsis Drug Mergers & Acquisitions in the Past Five Years
Table 54. Global Sepsis Drug Sales by Region (2017-2022) & (K Units)
Table 55. Global Sepsis Drug Sales by Region (2023-2028) & (K Units)
Table 56. Global Sepsis Drug Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Sepsis Drug Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Sepsis Drug Sales by Type (2017-2022) & (K Units)
Table 59. Global Sepsis Drug Sales by Type (2023-2028) & (K Units)
Table 60. Global Sepsis Drug Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Sepsis Drug Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Sepsis Drug Price by Type (2017-2022) & (US$/Unit)
Table 63. Global Sepsis Drug Price by Type (2023-2028) & (US$/Unit)
Table 64. Global Sepsis Drug Sales by Application (2017-2022) & (K Units)
Table 65. Global Sepsis Drug Sales by Application (2023-2028) & (K Units)
Table 66. Global Sepsis Drug Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Sepsis Drug Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Sepsis Drug Price by Application (2017-2022) & (US$/Unit)
Table 69. Global Sepsis Drug Price by Application (2023-2028) & (US$/Unit)
Table 70. North America Sepsis Drug Sales by Country (2017-2022) & (K Units)
Table 71. North America Sepsis Drug Sales by Country (2023-2028) & (K Units)
Table 72. North America Sepsis Drug Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Sepsis Drug Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Sepsis Drug Sales by Type (2017-2022) & (K Units)
Table 75. North America Sepsis Drug Sales by Type (2023-2028) & (K Units)
Table 76. North America Sepsis Drug Sales by Application (2017-2022) & (K Units)
Table 77. North America Sepsis Drug Sales by Application (2023-2028) & (K Units)
Table 78. Europe Sepsis Drug Sales by Country (2017-2022) & (K Units)
Table 79. Europe Sepsis Drug Sales by Country (2023-2028) & (K Units)
Table 80. Europe Sepsis Drug Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Sepsis Drug Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Sepsis Drug Sales by Type (2017-2022) & (K Units)
Table 83. Europe Sepsis Drug Sales by Type (2023-2028) & (K Units)
Table 84. Europe Sepsis Drug Sales by Application (2017-2022) & (K Units)
Table 85. Europe Sepsis Drug Sales by Application (2023-2028) & (K Units)
Table 86. Asia-Pacific Sepsis Drug Sales by Region (2017-2022) & (K Units)
Table 87. Asia-Pacific Sepsis Drug Sales by Region (2023-2028) & (K Units)
Table 88. Asia-Pacific Sepsis Drug Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Sepsis Drug Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Sepsis Drug Sales by Type (2017-2022) & (K Units)
Table 91. Asia-Pacific Sepsis Drug Sales by Type (2023-2028) & (K Units)
Table 92. Asia-Pacific Sepsis Drug Sales by Application (2017-2022) & (K Units)
Table 93. Asia-Pacific Sepsis Drug Sales by Application (2023-2028) & (K Units)
Table 94. South America Sepsis Drug Sales by Country (2017-2022) & (K Units)
Table 95. South America Sepsis Drug Sales by Country (2023-2028) & (K Units)
Table 96. South America Sepsis Drug Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Sepsis Drug Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Sepsis Drug Sales by Type (2017-2022) & (K Units)
Table 99. South America Sepsis Drug Sales by Type (2023-2028) & (K Units)
Table 100. South America Sepsis Drug Sales by Application (2017-2022) & (K Units)
Table 101. South America Sepsis Drug Sales by Application (2023-2028) & (K Units)
Table 102. Middle East & Africa Sepsis Drug Sales by Region (2017-2022) & (K Units)
Table 103. Middle East & Africa Sepsis Drug Sales by Region (2023-2028) & (K Units)
Table 104. Middle East & Africa Sepsis Drug Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Sepsis Drug Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Sepsis Drug Sales by Type (2017-2022) & (K Units)
Table 107. Middle East & Africa Sepsis Drug Sales by Type (2023-2028) & (K Units)
Table 108. Middle East & Africa Sepsis Drug Sales by Application (2017-2022) & (K Units)
Table 109. Middle East & Africa Sepsis Drug Sales by Application (2023-2028) & (K Units)
Table 110. Sepsis Drug Raw Material
Table 111. Key Manufacturers of Sepsis Drug Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Sepsis Drug Typical Distributors
Table 115. Sepsis Drug Typical Customers
List of Figures
Figure 1. Sepsis Drug Picture
Figure 2. Global Sepsis Drug Revenue Market Share by Type in 2021
Figure 3. Cephalosporin
Figure 4. Pencillin
Figure 5. Macrolides
Figure 6. Others
Figure 7. Global Sepsis Drug Revenue Market Share by Application in 2021
Figure 8. Sepsis
Figure 9. Severe Sepsis
Figure 10. Septic Shock
Figure 11. Global Sepsis Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Sepsis Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Sepsis Drug Sales (2017-2028) & (K Units)
Figure 14. Global Sepsis Drug Price (2017-2028) & (US$/Unit)
Figure 15. Global Sepsis Drug Production Capacity (2017-2028) & (K Units)
Figure 16. Global Sepsis Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Sepsis Drug Market Drivers
Figure 18. Sepsis Drug Market Restraints
Figure 19. Sepsis Drug Market Trends
Figure 20. Global Sepsis Drug Sales Market Share by Manufacturer in 2021
Figure 21. Global Sepsis Drug Revenue Market Share by Manufacturer in 2021
Figure 22. Sepsis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Sepsis Drug Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Sepsis Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Sepsis Drug Sales Market Share by Region (2017-2028)
Figure 26. Global Sepsis Drug Revenue Market Share by Region (2017-2028)
Figure 27. North America Sepsis Drug Revenue (2017-2028) & (USD Million)
Figure 28. Europe Sepsis Drug Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Sepsis Drug Revenue (2017-2028) & (USD Million)
Figure 30. South America Sepsis Drug Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Sepsis Drug Revenue (2017-2028) & (USD Million)
Figure 32. Global Sepsis Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Sepsis Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Sepsis Drug Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Sepsis Drug Sales Market Share by Application (2017-2028)
Figure 36. Global Sepsis Drug Revenue Market Share by Application (2017-2028)
Figure 37. Global Sepsis Drug Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Sepsis Drug Sales Market Share by Type (2017-2028)
Figure 39. North America Sepsis Drug Sales Market Share by Application (2017-2028)
Figure 40. North America Sepsis Drug Sales Market Share by Country (2017-2028)
Figure 41. North America Sepsis Drug Revenue Market Share by Country (2017-2028)
Figure 42. United States Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Sepsis Drug Sales Market Share by Type (2017-2028)
Figure 46. Europe Sepsis Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Sepsis Drug Sales Market Share by Country (2017-2028)
Figure 48. Europe Sepsis Drug Revenue Market Share by Country (2017-2028)
Figure 49. Germany Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Sepsis Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Sepsis Drug Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Sepsis Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Sepsis Drug Revenue Market Share by Region (2017-2028)
Figure 58. China Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Sepsis Drug Sales Market Share by Type (2017-2028)
Figure 65. South America Sepsis Drug Sales Market Share by Application (2017-2028)
Figure 66. South America Sepsis Drug Sales Market Share by Country (2017-2028)
Figure 67. South America Sepsis Drug Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Sepsis Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Sepsis Drug Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Sepsis Drug Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Sepsis Drug Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Sepsis Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Sepsis Drug in 2021
Figure 79. Manufacturing Process Analysis of Sepsis Drug
Figure 80. Sepsis Drug Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のゴセレリン薬物市場2022年：市場規模予測（～2028年）
  • 世界の神経線維腫症治療薬市場2022年：市場規模予測（～2028年）
  • 世界のCDK4及び6阻害医薬品市場2022年：市場規模予測（～2028年）
  • 世界のアフリベルセプト薬市場2022年：市場規模予測（～2028年）
  • 世界の軟骨形成術治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19620 )"世界の敗血症治療薬市場2022年：市場規模予測（～2028年）" (英文：Global Sepsis Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。